Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C1DQ
|
|||
| Former ID |
DIB020734
|
|||
| Drug Name |
ASN-11124542
|
|||
| Synonyms |
AC1O5VPR; ASN 11124542
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C13H8N4OS
|
|||
| Canonical SMILES |
C1=CC2=C(C3=C1NC(=O)C3=CC4=CN=CN4)SC=N2
|
|||
| InChI |
1S/C13H8N4OS/c18-13-8(3-7-4-14-5-15-7)11-9(17-13)1-2-10-12(11)19-6-16-10/h1-6H,(H,14,15)(H,17,18)/b8-3-
|
|||
| InChIKey |
VFBGXTUGODTSPK-BAQGIRSFSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tyrosine-protein kinase EIF2AK2 (p68) | Target Info | Inhibitor | [1] |
| Panther Pathway | Apoptosis signaling pathway | |||
| Pathway Interaction Database | Signaling events mediated by TCPTP | |||
| Ceramide signaling pathway | ||||
| PDGFR-beta signaling pathway | ||||
| Reactome | ISG15 antiviral mechanism | |||
| WikiPathways | Type II interferon signaling (IFNG) | |||
| Host Interactions with Influenza Factors | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| Translation Factors | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun. 2003 Aug 15;308(1):50-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.